0.9749

1.53% -0.0151

Kronos Bio Inc (KRON)

Overview News Price History Option Chain Financials Discussions Forecast

Kronos Bio Inc stock is traded at $0.9749, with a volume of 41,537. It is down -1.53% in the last 24 hours and down -3.00% over the past month. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Previous Close:

$0.99

Open:

$0.97

24h Volume:

41,537

Relative Volume:

0.14

Market Cap:

$59.74M

Revenue:

Net Income/Loss:

$-112.67M

P/E Ratio:

-0.4999

EPS:

-1.95

Net Cash Flow:

$-79.26M

1W Performance:

-3.48%

1M Performance:

-3.00%

6M Performance:

-12.17%

1Y Performance:

-7.15%

1-Day Range:

$0.9603

$1.00

1-Week Range:

$0.96

$1.03

52-Week Range:

$0.69

$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name

Kronos Bio Inc

Sector

Healthcare (1187)

Industry

Biotechnology (679)

Phone

(650) 781-5200

Address

1300 S. EL CAMINO REAL, SAN MATEO

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

KRON's Discussions on Twitter

Compare KRON with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KRON Kronos Bio Inc	0.975	59.74M	0	-112.67M	-79.26M	-1.95
VRTX Vertex Pharmaceuticals Inc	473.76	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	715.62	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	651.19	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	275.15	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.44	28.75B	3.30B	-501.07M	1.03B	-2.1146

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Downgrade	Piper Sandler	Overweight → Neutral
Nov-14-24	Downgrade	TD Cowen	Buy → Hold
Sep-14-22	Initiated	Berenberg	Buy
Oct-20-21	Resumed	Cowen	Outperform
Jun-24-21	Initiated	H.C. Wainwright	Buy
Nov-03-20	Initiated	Cowen	Outperform
Nov-03-20	Initiated	Goldman	Buy
Nov-03-20	Initiated	Jefferies	Buy
Nov-03-20	Initiated	Piper Sandler	Overweight

View All

Kronos Bio Inc Stock (KRON) Latest News

Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025

Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025

Jan 18, 2025

Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace

Jan 18, 2025

Jan 13, 2025

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 13, 2025

Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025

Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World

Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat

Jan 01, 2025

Dec 28, 2024

Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia

Dec 28, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024

Dec 02, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Dec 02, 2024

Dec 01, 2024